Company · CIK 0001642375 · SIC 2834 — Pharmaceutical Preparations
Guardion Health Sciences, Inc.
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2018 GJForm 4 → | Apr 3, 2:35 pm EDT | David W Evans +1Director | 3,050,000 | — | — | 2,992,000 | — | plan? |
| Aug 30, 2017 AForm 4 → | Aug 30, 7:33 pm EDT | John TownsendChief Accounting Officer | 100,000 | — | — | 105,000 | — | plan? |
| Dec 31, 2016 AForm 4/A → | Feb 14, 2017, 4:16 pm EST | Robert N WeingartenDirector | 50,000 | — | — | 1,300,000 | — | plan? |
| Dec 31, 2016 AForm 4/A → | Feb 14, 2017, 4:07 pm EST | Mark GoldstoneDirector | 50,000 | — | — | 1,050,000 | — | plan? |
| Dec 31, 2016 PForm 4/A → | Feb 14, 2017, 4:02 pm EST | Michael FavishChair, Chief Executive Officer, Director, 10% Owner | 684,933 | $0.60 | $410,960 | 6,234,933 | +12.3% | plan? |
| Dec 31, 2016 AForm 4/A → | Feb 14, 2017, 4:02 pm EST | Michael FavishChair, Chief Executive Officer, Director, 10% Owner | 60,000 | — | — | 260,000 | — | plan? |
| Dec 31, 2016 AForm 4/A → | Feb 14, 2017, 3:50 pm EST | Gordon BethwaiteVice Pres, Sales and Marketing | 20,000 | — | — | 270,000 | — | plan? |
| Dec 31, 2016 AForm 4/A → | Feb 14, 2017, 3:45 pm EST | John TownsendOther | 5,000 | — | — | 5,000 | — | plan? |
| Dec 31, 2016 AForm 4/A → | Feb 14, 2017, 3:38 pm EST | Vincent J RothGeneral Counsel and Secretary | 15,000 | — | — | 265,000 | — | plan? |
| Dec 31, 2016 AForm 4 → | Jan 3, 2017, 4:39 pm EST | Vincent J RothGeneral Counsel and Secretary | 15,000 | — | — | 265,000 | — | plan? amended |
| Dec 31, 2016 AForm 4 → | Jan 3, 2017, 4:36 pm EST | John TownsendOther | 5,000 | — | — | 5,000 | — | plan? amended |
| Dec 31, 2016 AForm 4 → | Jan 3, 2017, 4:31 pm EST | Gordon BethwaiteVice Pres, Sales and Marketing | 20,000 | — | — | 270,000 | — | plan? amended |
| Dec 31, 2016 AForm 4 → | Jan 3, 2017, 4:26 pm EST | Mark GoldstoneDirector | 50,000 | — | — | 1,050,000 | — | plan? amended |
| Dec 31, 2016 PForm 4 → | Jan 3, 2017, 4:21 pm EST | Michael FavishChair, Chief Executive Officer, Director, 10% Owner | 684,933 | $0.60 | $410,960 | 6,234,933 | +12.3% | plan? |
| Dec 31, 2016 AForm 4 → | Jan 3, 2017, 4:21 pm EST | Michael FavishChair, Chief Executive Officer, Director, 10% Owner | 60,000 | — | — | 160,000 | — | plan? |
| Dec 31, 2016 AForm 4 → | Jan 3, 2017, 4:06 pm EST | Robert N WeingartenDirector | 50,000 | — | — | 1,300,000 | — | plan? amended |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.